OPEN ORPHAN’S STOCK MARKET PRESCRIPTION

Cathal Friel

CATHAL FRIEL has been putting together a group of companies in the clinical research organisation sector. Rather than competing with the multi-billion euro Icon group (which grew out of Austin Darragh’s Institute of Clinical Pharmacology), Open Orphan is instead focused on offering a clinical services business targeting the so-called orphan drug sector. Although it is… Read more »